The effect of N-acetylcysteine on blood coagulation and platelet function in patients undergoing open repair of abdominal aortic aneurysm
- 1 January 2006
- journal article
- research article
- Published by Wolters Kluwer Health in Blood Coagulation & Fibrinolysis
- Vol. 17 (1) , 29-34
- https://doi.org/10.1097/01.mbc.0000195922.26950.89
Abstract
N-acetylcysteine (NAC) may offer renal and hepatic protection during surgery, but in experimental studies it has been shown to impair coagulation. Since very little is known about the effects of NAC on blood coagulation in surgical patients, we studied its effects during abdominal aortic reconstruction. NAC (a bolus of 150 mg/kg followed by a continuous 24-h infusion of 150 mg/kg) or the same volume of placebo was given intravenously, in a randomized double-blinded fashion, to 20 patients undergoing abdominal aortic aneurysm repair. The haematocrit, platelet count, prothrombin time, thromboelastometry, and platelet aggregation were studied during and after surgery. Total blood loss was also measured. The median (25th-75th percentiles) decrease of the prothrombin time value was 33.0% (30-37%) after NAC treatment and 6.5% (4-8%) after placebo (P<0.001). Postoperative prothrombin time values remained lower in the patients receiving NAC. In thromboelastometry tracings the coagulation time was more prolonged after the bolus of NAC (P=0.02). Platelet aggregation induced with adenosine diphosphate decreased after NAC but not after placebo. Low prothrombin time values before and after bolus infusions were associated with increased blood loss (P=0.008 and P=0.015, respectively). NAC has anticoagulant and platelet-inhibiting properties in patients undergoing major vascular surgery. This abnormal haemostatic activity should be considered when NAC is administered to patients with increased bleeding risk.Keywords
This publication has 22 references indexed in Scilit:
- Effect of intravenous N-acetylcysteine infusion on haemostatic parameters in healthy subjectsGut, 2005
- Acute liver failureCurrent Treatment Options in Gastroenterology, 2004
- Acetylcysteine for prevention of contrast nephropathy: meta-analysisThe Lancet, 2003
- Lack of Effect of Prophylactic N-acetylcysteine on Postoperative Organ Dysfunction following Major Abdominal Tumour Surgery: A Randomized, Placebo-controlled, Double-blinded Clinical TrialAnaesthesia and Intensive Care, 2003
- A Multiantioxidant Supplementation Reduces Damage from Ischaemia Reperfusion in Patients after Lower Torso Ischaemia. A Randomised TrialEuropean Journal of Vascular and Endovascular Surgery, 2002
- N‐acetyl‐L‐cysteine exerts direct anti‐aggregating effect on human plateletsEuropean Journal of Clinical Investigation, 2001
- N-Acetylcysteine treatment to prevent the progression of multisystem organ failureCritical Care Medicine, 1999
- Reduction of ischemia‐reperfusion syndrome after abdominal aortic aneurysmectomy by N‐acetylcysteine but not mannito1,2Acta Anaesthesiologica Scandinavica, 1996
- The influence of N-acetylcysteine on the measurement of prothrombin time and activated partial thromboplastin time in healthy subjectsScandinavian Journal of Clinical and Laboratory Investigation, 1994
- Antioxidant treatment with N-acetylcysteine during adult respiratory distress syndromeCritical Care Medicine, 1992